The Weekly Litigation News Digest is now live. Subscribe now

IP Verse

Novel Immune Checkpoint Inhibitors - EP3802922

The patent EP3802922 was granted to Boehringer Ingelheim on Apr 26, 2023. The application was originally filed on Jun 10, 2019 under application number EP19740098A. The patent is currently recorded with a legal status of "Revoked".

EP3802922

BOEHRINGER INGELHEIM
Application Number
EP19740098A
Filing Date
Jun 10, 2019
Status
Revoked
May 2, 2025
Publication Date
Apr 26, 2023
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

STRAWMANJan 26, 2024VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE

Patent Citations (11) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication Number
INTERNATIONAL-SEARCH-REPORTCN102393456B
INTERNATIONAL-SEARCH-REPORTCN110029168
INTERNATIONAL-SEARCH-REPORTKR20150037321
INTERNATIONAL-SEARCH-REPORTWO2010019570
INTERNATIONAL-SEARCH-REPORTWO2015042246
INTERNATIONAL-SEARCH-REPORTWO2017078318
INTERNATIONAL-SEARCH-REPORTWO2019141092
OPPOSITIONWO2010019570
OPPOSITIONWO2014008218
OPPOSITIONWO2015042246
OPPOSITIONWO2019241098

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents